To verify the assumption, we administered B. fragilis to mice in a DSS-induced colitis mouse model and found that B. fragilis facilitates colonic mucosa proliferation, and mucus secretion, and alters gut microbiota in colitis via motivating the STAT3 pathway induced by IL-22 from ILC3 secretion. Here, IL22 is linked to colitis.